Department of Breast Surgery, China Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun 130033, China.
Am J Surg. 2013 Jan;205(1):35-8. doi: 10.1016/j.amjsurg.2012.05.012. Epub 2012 Oct 1.
Although most breast abscesses can be treated with the current first-line treatment of antibiotics by needle aspiration, the therapeutic duration is lengthy and recurrences often occur. Therefore, we aimed to investigate the clinical efficacy of the Mammotome biopsy system (Johnson & Johnson Corp., New Brunswick, NJ) in a cohort of patients with breast abscesses.
Forty lactating and 30 nonlactating breast abscess patients with unfavorable outcomes with antibiotic treatment and/or needle aspiration failure were recruited and treated with the Mammotome biopsy system.
Skin inflammation of all patients disappeared within 6 days with no recurrence. The clinical outcomes in patients with an abscess size ≤ 3.5 cm was significantly better than those with an abscess size >3.5 cm (P = .025).
The Mammotome biopsy system, an effective treatment strategy that is minimally invasive and less damaging, in combination with appropriate antibiotic therapy can be used safely as the first-line approach to breast abscess management.
尽管大多数乳腺脓肿可以通过目前的一线治疗方法——经皮穿刺抽脓联合抗生素治疗，但治疗时间较长，且经常复发。因此，我们旨在研究 Mammotome 活检系统（强生公司，新泽西州新不伦瑞克省）在一组乳腺脓肿患者中的临床疗效。
招募了 40 例哺乳期和 30 例非哺乳期乳腺脓肿患者，这些患者在抗生素治疗和/或经皮穿刺抽脓失败后，应用 Mammotome 活检系统进行治疗。
所有患者的皮肤炎症在 6 天内消失，无复发。脓肿大小≤3.5cm 的患者的临床结局明显优于脓肿大小>3.5cm 的患者（P=0.025）。
Mammotome 活检系统是一种有效的治疗策略，微创且损伤较小，与适当的抗生素治疗相结合，可以作为乳腺脓肿管理的一线方法安全使用。
